The European Conference on Infections in Leukaemia (ECIL) brings together experts in several fields to produce evidence-based recommendations from comprehensive literature reviews. The 10th ECIL meeting in 2024 addressed new developments in CMV management after allogeneic HCT, and recommendations are presented in this Review. Management recommendations include diagnostics, such as immune monitoring, antiviral prophylaxis with letermovir, management of resistant and refractory CMV infections, and paediatric aspects of CMV management.
Details of the paper:
Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies
Author: Per Ljungman,Sophie Alain,Roy F Chemaly,Hermann Einsele,Federica Galaverna,Hans H Hirsch,Alicja Sadowska-Klasa,David Navarro,Jan Styczynski,Rafael de la Camara
Publication: The Lancet Infectious Diseases
Publisher: Elsevier
Date: Available online 3 April 2025
© 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
C-ANPROM/BE/LIV/0014 July 2025